Correlation Between Cytokinetics and Dyne Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytokinetics and Dyne Therapeutics, you can compare the effects of market volatilities on Cytokinetics and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Dyne Therapeutics.

Diversification Opportunities for Cytokinetics and Dyne Therapeutics

0.5

Correlation Coefficient

Cytokinetics  Dyne Therapeutics

Very weak diversification

The 3 months correlation between Cytokinetics and Dyne is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Cytokinetics i.e., Cytokinetics and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between Cytokinetics and Dyne Therapeutics

Given the investment horizon of 90 days Cytokinetics is expected to generate 0.6 times more return on investment than Dyne Therapeutics. However, Cytokinetics is 1.67 times less risky than Dyne Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Dyne Therapeutics is currently generating about -0.21 per unit of risk. If you would invest  5,186  in Cytokinetics on November 28, 2024 and sell it today you would lose (447.00) from holding Cytokinetics or give up 8.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cytokinetics  vs.  Dyne Therapeutics

Cytokinetics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cytokinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Dyne Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cytokinetics and Dyne Therapeutics

The main advantage of trading using opposite Cytokinetics and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.

The idea behind Cytokinetics and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.